PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
2 hedge funds and large institutions have $1.89M invested in PureTech Health in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0.21% less ownership
Funds ownership: 0.23% → 0.02% (-0.21%)
25% less capital invested
Capital invested by funds: $2.52M → $1.89M (-$629K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| 1 |
AIC
AWM Investment Company
New York
|
-$15.6M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $1.89M | -$15.6M | -590,000 | -89% |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | -$9.2K | -349 | -95% |
|
PRTC Hedge Fund Activity: Q3 2022 in Review
2 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q3 2022, worth a combined $1.89M — down 25% from $2.52M a quarter earlier.
Fund positioning in PRTC was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was AWM Investment Company, cutting an estimated $15.6M.
- 2 institutional investors held PureTech Health (PRTC) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $1.89M of PureTech Health stock for Q3 2022, down 25% quarter-over-quarter.
- 0 funds opened new PureTech Health positions in Q3 2022 and 0 closed out.
- The largest PureTech Health seller in Q3 2022 was AWM Investment Company, an estimated $15.6M sold.
Based on aggregated 13F filings for Q3 2022.